Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B

Jae-Jun Shim ,  In Hwan Oh ,  Sang Bae Kim 외 5명

Gut and Liver

2016 .01

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C

Lee Chang Hun ,  Kim In Hee

Gut and Liver

2021 .01

Hepatitis C Virus and Antiviral Drug Resistance

Seungtaek Kim ,  Kwang-Hyub Han ,  Sang Hoon Ahn

Gut and Liver

2016 .01

What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?

김진욱

Journal of Korean Medical Science

2019 .01

Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study

Kang Yeo Wool ,  Baek Yang Hyun ,  Lee Sung Wook 외 10명

Journal of Korean Medical Science

2021 .01

A Program to Treat Hepatitis B in North Korea: A Model of Antiviral Therapy in a Resource-Poor Setting

Alice Unah Lee ,  Heidi Linton ,  Ma 외 3명

Gut and Liver

2018 .01

Current and future strategies for the treatment of chronic hepatitis C

Oma ,  Alshuwaykh ,  Paul Y. Kwo

Clinical and Molecular Hepatology

2021 .01

Drug-drug interactions with direct-acting antivirals ? less is more

G ,  ace Lai-Hung Wong

Clinical and Molecular Hepatology

2021 .01

Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?

Jang Byoung Kuk

Journal of Korean Medical Science

2024 .01

Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data

기모란 ,  최화영 ,  김경아 외 2명

Gut and Liver

2017 .01

Immunotherapy for Chronic Hepatitis B Virus Infection

Antonio Be ,  toletti ,  Nina Le Be 외 1명

Gut and Liver

2018 .01

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis

Paul Kwo ,  Deepti D ,  onam 외 1명

Clinical and Molecular Hepatology

2020 .01

Another oral antiviral treatment, but still far away from hepatitis B virus cure

Tai-Chung Tseng

Clinical and Molecular Hepatology

2021 .01

Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose

Jang Eun Sun ,  Kim Kyung-Ah ,  Kim Young Seok 외 5명

Gut and Liver

2020 .01

Chronic Hepatitis C Virus Infection, Why Not Treat Now?

박경수

대한류마티스학회지

2018 .01

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Lilian Yan Liang ,  Vincent Wai-Sun Wong ,  G 외 3명

Clinical and Molecular Hepatology

2023 .01

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

The Ko ,  ean Association fo ,  the Study of the Live

Clinical and Molecular Hepatology

2018 .01

A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B

Yang Hyun Baek

Clinical and Molecular Hepatology

2020 .01

Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research

Ying-Nan Tsai ,  Jia-Ling Wu ,  Yao-Chun Hsu

Clinical and Molecular Hepatology

2024 .04

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B

Choi Jonggi

Gut and Liver

2023 .03